Literature DB >> 6638150

Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.

R V Lloyd.   

Abstract

Diethylstilbestrol (DES) treatment of weanling F344 female rats resulted in enlarged pituitary glands and diffuse pituitary prolactin (PRL) cell hyperplasia in all animals after 9 and 12 weeks of treatment. Serum PRL was significantly greater than in control rats (P less than 0.001). Immunohistochemical studies showed that most of the pituitary gland cells consisted of PRL cells. Ultrastructural studies showed increased numbers of PRL cells with hyperplasia of the rough endoplasmic reticulum and decreased numbers of secretory granules. There was a decrease in the relative number of growth hormone (GH) and other cell types in the anterior pituitary. Pituitary tumors and normal pituitary glands were dissociated with trypsin and maintained in culture for 3 weeks. The numbers of PRL and GH cells decreased with time in both groups, and there was an increase in the number of fibroblasts. Staining of the culture cells with neuron-specific enolase showed that the anterior pituitary cells were positive for this enzyme, while the fibroblastic cells were negative. When dissociated pituitary cells were cultured in the presence of 10(-9) M DES for 7 days, there was a 42% increase in the number of immunoreactive PRL cells. These results indicate that DES-treated rats provide an excellent model for study of the in vivo and in vitro regulation of pituitary hyperplasia and neoplasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6638150      PMCID: PMC1916372     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Mechanism of anterior pituitary tumor induction by estrogen.

Authors:  K H CLIFTON; R K MEYER
Journal:  Anat Rec       Date:  1956-05

3.  Effects of LH-RH on isolated pituitary gonadotropic cells.

Authors:  R V Lloyd; W H McShan
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

4.  Enzymatic dissociation and short-term culture of isolated rat anterior pituitary cells for studies on the control of hormone secretion.

Authors:  H Nakano; C P Fawcett; S M McCann
Journal:  Endocrinology       Date:  1976-02       Impact factor: 4.736

Review 5.  Pituitary adenomas.

Authors:  K Kovacs; E Horvath; C Ezrin
Journal:  Pathol Annu       Date:  1977

6.  Steroid hormone uptake by anterior pituitary cell suspensions.

Authors:  W W Leavitt; G L Kimmel; J P Friend
Journal:  Endocrinology       Date:  1973-01       Impact factor: 4.736

7.  MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.

Authors:  K B Horwitz; M E Costlow; W L McGuire
Journal:  Steroids       Date:  1975-12       Impact factor: 2.668

8.  Control of cell growth. I. Estrogen-dependent growth in vivo of a rat pituitary tumor cell line.

Authors:  J M Sorrentino; W L Kirkland; D A Sirbasku
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

9.  Control of cell growth. II. Requirement of thyroid hormones for the in vivo estrogen-dependent growth of rat pituitary tumor cells.

Authors:  J M Sorrentino; W L Kirkland; D A Sirbasku
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

10.  Culture of human pituitary prolactin and growth hormone cells.

Authors:  J Snyder; W C Hymer; W W Wilfinger
Journal:  Cell Tissue Res       Date:  1978-08-16       Impact factor: 5.249

View more
  51 in total

Review 1.  Endocrine/paracrine control of pituitary cell proliferation and its involvement in pituitary tumorigenesis.

Authors:  M Pawlikowski
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Different ultrastructural localization of VIP and prolactin in anterior pituitary cells of rats chronically treated with estrogen.

Authors:  K Köves; I L Chen; T J Görcs; J G Scammell; A Arimura
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

3.  Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess.

Authors:  Hellevi Peltoketo; Leena Strauss; Riikka Karjalainen; Meilin Zhang; Gordon W Stamp; Deborah L Segaloff; Matti Poutanen; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

4.  Estrogen downregulates neuronal nitric oxide synthase in rat anterior pituitary cells and GH3 tumors.

Authors:  X Qian; L Jin; R V Lloyd
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

5.  Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat.

Authors:  Douglas L Wendell; Adrian Platts; Susan Land
Journal:  J Steroid Biochem Mol Biol       Date:  2006-09-26       Impact factor: 4.292

6.  Isolation and characterization of rat pituitary endothelial cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

7.  Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.

Authors:  Lei Cao; Hua Gao; Songbai Gui; Giwei Bai; Runchun Lu; Fei Wang; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2014-01-10       Impact factor: 4.130

8.  Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors.

Authors:  R V Lloyd; T D Landefeld; I Maslar; L A Frohman
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

9.  Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.

Authors:  D B DeStephano; R V Lloyd; A M Pike; B S Wilson
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

10.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.